Dashboard
Manage Tickers

RCMR1 RCM Holdco Inc.

Nasdaq www.r1rcm.com


$ 10.95 $ -0.18 (-1.62 %)    

Friday, 05-Jul-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 10.95
$ 11.13
$ 0.00 x 0
$ 10.96 x 216
$ 10.90 - $ 11.13
$ 8.87 - $ 18.71
1,914,615
na
3.52B
$ 0.94
$ 34.88
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2022 03-31-2022 10-Q
2 02-17-2022 12-31-2021 10-K
3 11-02-2021 09-30-2021 10-Q
4 08-03-2021 06-30-2021 10-Q
5 05-04-2021 03-31-2021 10-Q
6 02-18-2021 12-31-2020 10-K
7 11-03-2020 09-30-2020 10-Q
8 08-05-2020 06-30-2020 10-Q
9 05-05-2020 03-31-2020 10-Q
10 02-20-2020 12-31-2019 10-K
11 11-05-2019 09-30-2019 10-Q
12 08-06-2019 06-30-2019 10-Q
13 05-09-2019 03-31-2019 10-Q
14 02-22-2019 12-31-2018 10-K
15 11-07-2018 09-30-2018 10-Q
16 08-09-2018 06-30-2018 10-Q
17 05-10-2018 03-31-2018 10-Q
18 03-09-2018 12-31-2017 10-K
19 10-31-2017 09-30-2017 10-Q
20 08-02-2017 06-30-2017 10-Q
21 05-09-2017 03-31-2017 10-Q
22 03-01-2017 12-31-2016 10-K
23 11-02-2016 09-30-2016 10-Q
24 08-04-2016 06-30-2016 10-Q
25 05-10-2016 03-31-2016 10-Q
26 03-10-2016 12-31-2015 10-K
27 11-09-2015 09-30-2015 10-Q
28 08-05-2015 06-30-2015 10-Q
29 07-07-2015 03-31-2015 10-Q
30 06-23-2015 03-31-2014 10-Q
31 06-23-2015 06-30-2014 10-Q
32 06-23-2015 09-30-2014 10-Q
33 06-23-2015 12-31-2014 10-K
34 12-30-2014 12-31-2013 10-K
35 11-08-2012 09-30-2012 10-Q
36 08-09-2012 06-30-2012 10-Q
37 05-09-2012 03-31-2012 10-Q
38 02-29-2012 12-31-2011 10-K
39 11-10-2011 09-30-2011 10-Q
40 08-12-2011 06-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stocks-hold-steady-as-powell-reassures-on-disinflation-path-warns-about-debt-risks-tesla-rallies-job-openings-spike-whats-driving-markets-tuesday
Stocks Hold Steady As Powell Reassures On ...
07/02/2024 17:41:40

U.S. equities were little moved on Tuesday as investors continued to assess the potential for interest rate cuts following the ...

baird-maintains-outperform-on-r1-rcm-maintains-18-price-target
Baird Maintains Outperform on R1 RCM, Main...
07/02/2024 16:21:28

Baird analyst Vikram Kesavabhotla maintains R1 RCM (NASDAQ:RCM) with a Outperform and maintains $18 price target.

cantor-fitzgerald-reiterates-overweight-on-r1-rcm-maintains-20-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/02/2024 15:17:40

Cantor Fitzgerald analyst Sarah James reiterates R1 RCM (NASDAQ:RCM) with a Overweight and maintains $20 price target.

Core News & Articles
Market-Moving News for July 2nd
07/02/2024 12:29:43

RDZN: 81% | Roadzen shares are trading higher following FY24 earnings. RCM: -10% | R1 RCM shares are trading lower after the c...

r1-rcm-says-discussions-have-not-resulted-in-any-agreement-to-date-and-new-mountain-capital-is-no-longer-interested-in-pursuing-a-joint-proposal-with-tcp-asc-with-respect-to-a-potential-transaction-with-the-company
R1 RCM Says Discussions Have Not Resulted ...
07/02/2024 11:05:58

6-analysts-assess-r1-rcm-what-you-need-to-know
6 Analysts Assess R1 RCM: What You Need To...
06/28/2024 14:01:18

rbc-capital-reiterates-outperform-on-r1-rcm-maintains-19-price-target
RBC Capital Reiterates Outperform on R1 RC...
06/28/2024 13:29:01

RBC Capital analyst Sean Dodge reiterates R1 RCM (NASDAQ:RCM) with a Outperform and maintains $19 price target.

critical-insights-from-r1-rcm-analyst-ratings-what-you-need-to-know
Critical Insights From R1 RCM Analyst Rati...
06/11/2024 12:00:54

rbc-capital-reiterates-outperform-on-r1-rcm-maintains-19-price-target
RBC Capital Reiterates Outperform on R1 RC...
06/11/2024 11:40:22

RBC Capital analyst Sean Dodge reiterates R1 RCM (NASDAQ:RCM) with a Outperform and maintains $19 price target.

canaccord-genuity-maintains-buy-on-r1-rcm-lowers-price-target-to-15
Canaccord Genuity Maintains Buy on R1 RCM,...
05/09/2024 19:01:06

Canaccord Genuity analyst Richard Close maintains R1 RCM (NASDAQ:RCM) with a Buy and lowers the price target from $16 to $15.

r1-rcm-lowers-fy24-outlook-projects-revenues-of-260b-264b-vs-264b-estimate-prior-view-2625b-2675b-sees-adjusted-ebitda-of-625m-650m-prior-view-650m-670m
R1 RCM Lowers FY24 Outlook: Projects Reven...
05/08/2024 11:14:37

For 2024, R1 now expects to generate: Revenue of $2.60 billion to $2.64 billion GAAP operating income of $85 million to $10...

r1-rcm-q1-eps-008-misses-001-estimate-sales-60390m-miss-60977m-estimate
R1 RCM Q1 EPS $(0.08) Misses $(0.01) Estim...
05/08/2024 11:08:27

R1 RCM (NASDAQ:RCM) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.01) by 70...

cantor-fitzgerald-reiterates-overweight-on-r1-rcm-maintains-20-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 14:25:11

Cantor Fitzgerald analyst Sarah James reiterates R1 RCM (NASDAQ:RCM) with a Overweight and maintains $20 price target.

keybanc-downgrades-r1-rcm-to-sector-weight
Keybanc Downgrades R1 RCM to Sector Weight
04/10/2024 08:46:24

Keybanc analyst Scott Schoenhaus downgrades R1 RCM (NASDAQ:RCM) from Overweight to Sector Weight.

the-latest-analyst-ratings-for-r1-rcm
The Latest Analyst Ratings For R1 RCM
04/05/2024 17:00:16

guggenheim-maintains-buy-on-r1-rcm-lowers-price-target-to-15
Guggenheim Maintains Buy on R1 RCM, Lowers...
04/05/2024 14:34:36

Guggenheim analyst Jack Wallace maintains R1 RCM (NASDAQ:RCM) with a Buy and lowers the price target from $17 to $15.

truist-securities-maintains-hold-on-r1-rcm-maintains-16-price-target
Truist Securities Maintains Hold on R1 RCM...
04/01/2024 12:56:58

Truist Securities analyst Jailendra Singh maintains R1 RCM (NASDAQ:RCM) with a Hold and maintains $16 price target.

morgan-stanley-reiterates-overweight-on-r1-rcm-maintains-17-price-target
Morgan Stanley Reiterates Overweight on R1...
03/26/2024 16:16:34

Morgan Stanley analyst Craig Hettenbach reiterates R1 RCM (NASDAQ:RCM) with a Overweight and maintains $17 price target.

analyst-scoreboard-12-ratings-for-r1-rcm
Analyst Scoreboard: 12 Ratings For R1 RCM
03/20/2024 12:00:44

canaccord-genuity-maintains-buy-on-r1-rcm-lowers-price-target-to-16
Canaccord Genuity Maintains Buy on R1 RCM,...
03/20/2024 11:45:55

Canaccord Genuity analyst Richard Close maintains R1 RCM (NASDAQ:RCM) with a Buy and lowers the price target from $17 to $16.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)